- Home
- PAVS vs PDSB Comparison
PAVS vs PDSB Comparison
Compare PAVS & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- PDSB
- Stock Information
- Founded
- PAVS 2004
- PDSB 2005
- Country
- PAVS United States
- PDSB United States
- Employees
- PAVS N/A
- PDSB N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- PDSB Health Care
- Exchange
- PAVS Nasdaq
- PDSB Nasdaq
- Market Cap
- PAVS 89.6M
- PDSB 72.2M
- IPO Year
- PAVS 2019
- PDSB N/A
- Fundamental
- Price
- PAVS $1.00
- PDSB $1.41
- Analyst Decision
- PAVS
- PDSB Strong Buy
- Analyst Count
- PAVS 0
- PDSB 2
- Target Price
- PAVS N/A
- PDSB $10.00
- AVG Volume (30 Days)
- PAVS 12.3K
- PDSB 738.2K
- Earning Date
- PAVS 01-01-0001
- PDSB 05-14-2025
- Dividend Yield
- PAVS N/A
- PDSB N/A
- EPS Growth
- PAVS N/A
- PDSB N/A
- EPS
- PAVS N/A
- PDSB N/A
- Revenue
- PAVS $6,613,273.00
- PDSB N/A
- Revenue This Year
- PAVS N/A
- PDSB N/A
- Revenue Next Year
- PAVS N/A
- PDSB N/A
- P/E Ratio
- PAVS N/A
- PDSB N/A
- Revenue Growth
- PAVS 2.50
- PDSB N/A
- 52 Week Low
- PAVS $0.32
- PDSB $0.85
- 52 Week High
- PAVS $1.50
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- PAVS 41.77
- PDSB 53.22
- Support Level
- PAVS $0.94
- PDSB $1.33
- Resistance Level
- PAVS $1.08
- PDSB $1.47
- Average True Range (ATR)
- PAVS 0.06
- PDSB 0.12
- MACD
- PAVS 0.01
- PDSB -0.01
- Stochastic Oscillator
- PAVS 55.50
- PDSB 36.04
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.